Trailblazing the first trifunctional Effector Cell Response Inhibitors (ECRIs) to deliver rapid and complete control of allergic disease.
Excellergy Inc.
Immunology
Total Addressable Market
Red Tree Board Member(s)
Red Tree Board Members
Heath Lukatch, Ph.D.
Red Tree Board Observer
Jennifer Cochran, Ph.D.
Affiliated with Red Tree SAB Member
Red Tree Participation
Led seed round, co-investor in Series A